Restorative Parkinson Unit

Organisational unit: Research group

More filtering options
  1. 2021
  2. The Non-Motor Symptoms Scale in Parkinson’s disease: Validation and use

    Daniel J. van Wamelen, Pablo Martinez-Martin, Daniel Weintraub, Anette Schrag, Angelo Antonini, Cristian Falup-Pecurariu, Per Odin & Kallol Ray Chaudhuri, 2021 Jan, In : Acta Neurologica Scandinavica. 143, 1, p. 3-12 10 p.

    Research output: Contribution to journalReview article

  3. 2020
  4. Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease

    Beata Lindholm, Christina Brogårdh, Peter Hagell & Christer Nilsson, 2020 Sep 12, p. 549. 1 p.

    Research output: Contribution to conferenceAbstract

  5. Levodopa infusion in Parkinson's disease: Individual quality of life

    Claas Ehlers, Jonathan Timpka, Per Odin & Holger Honig, 2020 Sep, In : Acta Neurologica Scandinavica. 142, 3, p. 248-254 7 p.

    Research output: Contribution to journalArticle

  6. The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism

    Adrianus L.A.J. Hommel, Marjan J. Meinders, Stefan Lorenzl, Richard Dodel, Miguel Coelho, Joaquim J. Ferreira, Brice Laurens, Umberto Spampinato, Wassilios Meissner, Kristina Rosqvist, Jonathan Timpka, Per Odin, Michael Wittenberg, Bas R. Bloem PhD, Raymond T. Koopmans, Anette Schrag & Care of Late-Stage Parkinsonism Consortium Care of Late-Stage Parkinsonism Consortium, 2020 Jul, In : Movement Disorders Clinical Practice. 7, 5, p. 531-542 12 p.

    Research output: Contribution to journalArticle

  7. A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

    Per Svenningsson, Per Odin, Nil Dizdar, Anders Johansson, Sotirios Grigoriou, Panagiota Tsitsi, Klas Wictorin, Filip Bergquist, Dag Nyholm, Juha Rinne, Fredrik Hansson, Clas Sonesson, Joakim Tedroff & IRL752 Collaborators IRL752 Collaborators, 2020 Jun, In : Movement Disorders. 35, 6, p. 1046-1054 9 p.

    Research output: Contribution to journalArticle

  8. Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey

    A. Rizos, A. Sauerbier, C. Falup-Pecurariu, P. Odin, A. Antonini, P. Martinez-Martin, B. Kessel, T. Henriksen, M. Silverdale, G. Durner, K. Ray Chaudhuri & EUROPAR and the IPMDS Non-Motor PD Study Group EUROPAR and the IPMDS Non-Motor PD Study Group, 2020 May 5, In : Journal of Neural Transmission. 127, 6, p. 875-879 5 p.

    Research output: Contribution to journalArticle

  9. Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience

    Alfonso Fasano, Angelo Antonini, Regina Katzenschlager, Paul Krack, Per Odin, Andrew H. Evans, Thomas Foltynie, Jens Volkmann & Marcelo Merello, 2020 May, In : Movement Disorders Clinical Practice. 7, 4, p. 361-372 12 p.

    Research output: Contribution to journalReview article

  10. Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) zur Erhebung nichtmotorischer Symptome bei Dystonie: Interkulturelle Adaptation in deutscher Sprache

    L. Klingelhoefer, W. Jost, P. Odin, A. Storch, K. Ray Chaudhuri & H. Reichmann, 2020 Mar 6, In : Nervenarzt. 91, p. 337–342 6 p.

    Research output: Contribution to journalArticle

  11. Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson’s Disease

    Jenny Hultqvist, Thomas Sahlström, Jonathan Timpka, Tove Henriksen, Dag Nyholm, Per Odin & Mona Eklund, 2020, In : Occupational Therapy in Health Care. 34, 1, p. 1-18 18 p.

    Research output: Contribution to journalArticle

  12. Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia

    Gertrúd Tamás, Margherita Fabbri, Cristian Falup-Pecurariu, Tiago Teodoro, Mónica M. Kurtis, Rahim Aliyev, Michael Bonello, Hana Brozova, Miguel Soares Coelho, Maria Fiorella Contarino, Jean Christophe Corvol, Espen DIetrichs, Mouna Ben Djebara, Søren Bruno Elmgreen, Sergiu Groppa, Liis Kadastik-Eerme, Irine Khatiashvili, Vladimir Kostić, Florian Krismer, Alia Hassan Mansour & 15 others, Per Odin, Olga Gavriliuc, DIana Angelika Olszewska, Maja Relja, Filip Scheperjans, Matej Skorvanek, Katarzyna Smilowska, Pille Taba, Zaruhi Tavadyan, Ramona Valante, Balsa Vujovic, Daniel Waldvogel, Gul Yalcin-Cakmakli, Shilpa Chitnis & Joaquim J. Ferreira, 2020, In : Journal of Parkinson's Disease. 10, 4, p. 1833-1843 11 p.

    Research output: Contribution to journalArticle

  13. Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial

    Adrianus L.A.J. Hommel, Marjan J. Meinders, Nico J. Weerkamp, Carmen Richinger, Christian Schmotz, Stefan Lorenzl, Richard Dodel, Miguel Coelho, Joaquim J. Ferreira, Francois Tison, Thomas Boraud, Wassilios G. Meissner, Kristina Rosqvist, Jonathan Timpka, Per Odin, Michael Wittenberg, Bas R. Bloem, Raymond T. Koopmans, Anette Schragand & Care of Late Stage Parkinsonism (CLaSP) Consortium Care of Late Stage Parkinsonism (CLaSP) Consortium, 2020, In : Journal of Parkinson's Disease. 10, 3, p. 1171-1184 14 p.

    Research output: Contribution to journalArticle

  14. The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications

    A. Schrag, A. L.A.J. Hommel, S. Lorenzl, W. G. Meissner, P. Odin, M. Coelho, B. R. Bloem, R. Dodel & the CLaSP consortium the CLaSP consortium, 2020, In : Parkinsonism and Related Disorders. 75, p. 91-96 6 p.

    Research output: Contribution to journalArticle

  15. 2019
  16. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

    Haidar S. Dafsari, Pablo Martinez-Martin, Alexandra Rizos, Maja Trost, Maria Gabriela dos Santos Ghilardi, Prashanth Reddy, Anna Sauerbier, Jan Niklas Petry-Schmelzer, Milica Kramberger, Robbert W.K. Borgemeester, Michael T. Barbe, Keyoumars Ashkan, Monty Silverdale, Julian Evans, Per Odin, Erich Talamoni Fonoff, Gereon R. Fink, Tove Henriksen, Georg Ebersbach, Zvezdan Pirtošek & 5 others, Veerle Visser-Vandewalle, Angelo Antonini, Lars Timmermann, K. Ray Chaudhuri & EUROPAR EUROPAR , 2019 Feb 4, In : Movement Disorders.

    Research output: Contribution to journalArticle

  17. Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease

    Alexander Storch, Kristina Rosqvist, Georg Ebersbach, Per Odin & NoMoFlu-PD Study Group NoMoFlu-PD Study Group, 2019, In : Journal of Neural Transmission. 126, 7, p. 841-851

    Research output: Contribution to journalArticle

  18. Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study

    Andreas Puschmann, Itzia Jiménez-Ferrer, Elin Lundblad-Andersson, Emma Mårtensson, Oskar Hansson, Per Odin, Håkan Widner, Kajsa Brolin, Ropafadzo Mzezewa, Jonas Kristensen, Maria Soller, Emil Ygland Rödström, Owen A. Ross, Mathias Toft, Guido J. Breedveld, Vincenzo Bonifati, Lovisa Brodin, Anna Zettergren, Olof Sydow, Jan Linder & 6 others, Karin Wirdefeldt, Per Svenningsson, Hans Nissbrandt, Andrea Carmine Belin, Lars Forsgren & Maria Swanberg, 2019, In : Parkinsonism and Related Disorders. 66, p. 158-165

    Research output: Contribution to journalArticle

  19. Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease

    Pablo Martinez-Martin, Alexandra M. Rizos, John B. Wetmore, Angelo Antonini, Per Odin, Suvankar Pal, Rani Sophia, Camille Carroll, Davide Martino, Cristian Falup-Pecurariu, Belinda Kessel, Thomasin Andrews, Dominic Paviour, Claudia Trenkwalder, Kallol Ray Chaudhuri & EUROPAR & MDS Non-Motor PD Study Group EUROPAR & MDS Non-Motor PD Study Group, 2019, In : Movement Disorders Clinical Practice. 6, 1, p. 57-64

    Research output: Contribution to journalArticle

  20. Satisfaction with care in late stage Parkinson's disease

    Kristina Rosqvist, Peter Hagell, Susanne Iwarsson, Maria H. Nilsson & Per Odin, 2019, In : Parkinson's Disease. 2019, 10 p., 2593547.

    Research output: Contribution to journalArticle

  21. 2018
  22. Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave

    Jonathan Timpka, Örjan Dahlström, Armin Spreco, Maria H Nilsson, Susanne Iwarsson, Toomas Timpka & Per Odin, 2018 Dec 12, In : npj Parkinson's Disease. 4, 36.

    Research output: Contribution to journalArticle

  23. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach

    Angelo Antonini, A. Jon Stoessl, Leah S. Kleinman, Anne M. Skalicky, Thomas S. Marshall, Kavita R. Sail, Koray Onuk & Per Lars Anders Odin, 2018 Dec 2, In : Current Medical Research and Opinion. 34, 12, p. 2063-2073

    Research output: Contribution to journalArticle

  24. Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study

    Monika Balzer-Geldsetzer, Joaquim Ferreira, Per Odin, Bastiaan R. Bloem, Wassilios G. Meissner, Stefan Lorenzl, Michael Wittenberg, Richard Dodel & Anette Schrag, 2018 Nov 5, In : BMC Neurology. 18, 1, 185.

    Research output: Contribution to journalArticle

  25. Dopaminergic effect on non-motor symptoms in late stage Parkinson's disease

    Kristina Rosqvist, Per Odin, Peter Hagell, Susanne Iwarsson, Maria H. Nilsson & Alexander Storch, 2018 Jul 5, In : Journal of Parkinson's Disease. 8, 3, p. 409-420 12 p.

    Research output: Contribution to journalArticle

  26. Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson's disease

    Daniel J. Van Wamelen, Sotirios Grigoriou, K. Ray Chaudhuri & Per Odin, 2018, In : Journal of Parkinson's Disease. 8, s1, p. S65-S72

    Research output: Contribution to journalReview article

  27. First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire

    P. Martinez-Martin, A. M. Rizos, J. Wetmore, A. Antonini, P. Odin, S. Pal, R. Sophia, C. Carroll, D. Martino, C. Falup-Pecurariu, B. Kessel, T. Andrews, D. Paviour, C. Trenkwalder, K. R. Chaudhuri, EUROPAR EUROPAR & MDS Non-motor PD Study Group MDS Non-motor PD Study Group, 2018, In : European Journal of Neurology. 25, 10, p. 1255-1261 7 p.

    Research output: Contribution to journalArticle

  28. King’s Parkinson’s Disease Pain Scale: Interkulturelle Adaption in deutscher Sprache

    W. H. Jost, A Rizos, P. Odin, Matthias Löhle & A. Storch, 2018, In : Nervenarzt. 89, 2, p. 178-183

    Research output: Contribution to journalArticle

  29. Levodopa effect and motor function in late stage Parkinson's disease

    Kristina Rosqvist, Malcolm Horne, Peter Hagell, Susanne Iwarsson, Maria H. Nilsson & Per Odin, 2018, In : Journal of Parkinson's Disease. 8, 1, p. 59-70 12 p.

    Research output: Contribution to journalArticle

  30. Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics

    David G Standaert, James T Boyd, Per Odin, Weining Z Robieson, Jorge Zamudio & Krai Chatamra, 2018, In : npj Parkinson's Disease. 4, p. 1-6 4.

    Research output: Contribution to journalArticle

  31. Towards a better care for late stage Parkinson's disease

    Kristina Rosqvist, 2018, Lund: Lund University: Faculty of Medicine. 97 p.

    Research output: ThesisDoctoral Thesis (compilation)

  32. Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease

    Per Odin, K Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos & Filip Bergquist, 2018, In : npj Parkinson's Disease. 4, p. 1-7 14.

    Research output: Contribution to journalReview article

  33. Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy

    T. Sahlström, M. Eklund, J. Timpka, T. Henriksen, D. Nyholm & P. Odin, 2018, In : Acta Neurologica Scandinavica. 138, 1, p. 78-84

    Research output: Contribution to journalArticle

  34. 2017
  35. Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

    Maria José Catalán, Angelo Antonini, Matilde Calopa, Ovidiu Băjenaru, Oriol de Fábregues, Adolfo Mínguez-Castellanos, Per Odin, José Manuel García-Moreno, Stephen W. Pedersen, Zvezdan Pirtošek & Jaime Kulisevsky, 2017 Sep 1, In : eNeurologicalSci. 8, p. 44-53 10 p.

    Research output: Contribution to journalReview article

  36. Factors associated with perceived walking difficulties in people with Parkinson’s disease

    Manzur Kader, Susann Ullén, Susanne Iwarsson, Per Odin & Maria Nilsson, 2017 Jun, In : Movement Disorders. 32, Suppl. 2, 1374.

    Research output: Contribution to journalPublished meeting abstract

  37. Algorithms for the treatment of motor problems in Parkinson's disease

    E Dietrichs & P. Odin, 2017, In : Acta Neurologica Scandinavica. 136, 5, p. 378-385

    Research output: Contribution to journalArticle

  38. Device-Aided Treatment Strategies in Advanced Parkinson's Disease

    Jonathan Timpka, Bianca Nitu, Veronika Datieva, Per Odin & Angelo Antonini, 2017, In : International Review of Neurobiology. 132, p. 453-474

    Research output: Contribution to journalArticle

  39. Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale

    Pablo Martinez-Martin, Jose Manuel Rojo-Abuin, Alexandra Rizos, Carmen Rodriguez-Blazquez, Claudia Trenkwalder, Lauren Perkins, Anna Sauerbier, Per Odin, Angelo Antonini & Kallol Ray Chaudhuri, 2017, In : npj Parkinson's Disease. 3, p. 1-6 8.

    Research output: Contribution to journalArticle

  40. Etiology and pathogenesis of parkinson’s disease

    Jonathan Timpka, Maria Angela Cenci & Per Odin, 2017, Movement Disorders Curricula. Springer, p. 95-101 7 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  41. Factors associated with perceived walking difficulties in people with Parkinson’s disease

    Manzur Kader, Susann Ullén, Susanne Iwarsson, Per Odin & Maria H Nilsson, 2017.

    Research output: Contribution to conferenceAbstract

  42. Infusional Therapies, Continuous Dopaminergic Stimulation, and Nonmotor Symptoms

    Ulrika Mundt-Petersen & Per Odin, 2017, Parkinson’s: The Hidden Face Management and the Hidden Face of Related Disorders. Chaudhuri, R. & Titova, N. (eds.). Elsevier, p. 1019-1044 (International Review of Neurobiology; vol. 134).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  43. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

    Angelo Antonini, Werner Poewe, K. Ray Chaudhuri, Robert Jech, Barbara Pickut, Zvezdan Pirtošek, Jozsef Szasz, Francesc Valldeoriola, Christian Winkler, Lars Bergmann, Ashley Yegin, Koray Onuk, David Barch & Per Odin, 2017, In : Parkinsonism and Related Disorders. 45, p. 13-20

    Research output: Contribution to journalArticle

  44. Levodopa effect and motor function in late stage Parkinson’s disease

    Kristina Rosqvist, M Horne, Peter Hagell, Susanne Iwarsson, Maria H Nilsson & Per Odin, 2017, p. Abstract number: 1360.

    Research output: Contribution to conferenceAbstract

  45. The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden

    Peter Hagell, Maria H Nilsson, K Ray Chaudhuri & Per Odin, 2017.

    Research output: Contribution to conferenceAbstract

  46. 2016
  47. Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease: For Whom, When, and How?

    Jonathan Timpka, Tove Henriksen & Per Odin, 2016 Mar 24, In : Movement Disorders Clinical Practice. 3, 3, p. 221-229

    Research output: Contribution to journalReview article

  48. Perceived walking difficulties in relation to motor aspects in Parkinson’s disease

    Manzur Kader, Susanne Iwarsson, Per Odin & Maria H Nilsson, 2016.

    Research output: Contribution to conferenceAbstract

  49. 2015
  50. Fall-related activity avoidance in people ageing with Parkinson’s disease

    Maria H Nilsson, Manzur Kader, Per Odin & Susanne Iwarsson, 2015.

    Research output: Contribution to conferenceAbstract

  51. 2009
  52. Dopamine replacement therapy in Parkinson´s Disease: past, present and future

    Angela Cenci Nilsson & Per Odin, 2009, Cortico-Subcortical Dynamics in Parkinson’s Disease. Tseng, K-Y. (ed.). Springer International Publishing, p. 309-334

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  53. 1995
  54. Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro

    A Othberg, P Odin, A Ballagi, A Ahgren, K Funa & O Lindvall, 1995, In : Experimental Brain Research. 105, 1, p. 111-22 12 p.

    Research output: Contribution to journalArticle

  55. 1994
  56. Pravidel kan ge lungförändringar. Aktivitetstecken och viktnedgång ingår i bilden

    E Vinge, P Odin, L Hansson, H Widner & O Lindvall, 1994 Nov 9, In : Läkartidningen. 91, 45, p. 4116-8

    Research output: Contribution to journalArticle

  57. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease

    O Lindvall, Guy Sawle, H Widner, J C Rothwell, A Björklund, D E Brooks, P Brundin, R S Frackowiak, C D Marsden & P Odin, 1994 Feb, In : Annals of Neurology. 35, 2, p. 172-80

    Research output: Contribution to journalArticle

Previous 1 2 Next